JP2017534056A5 - - Google Patents

Download PDF

Info

Publication number
JP2017534056A5
JP2017534056A5 JP2017523343A JP2017523343A JP2017534056A5 JP 2017534056 A5 JP2017534056 A5 JP 2017534056A5 JP 2017523343 A JP2017523343 A JP 2017523343A JP 2017523343 A JP2017523343 A JP 2017523343A JP 2017534056 A5 JP2017534056 A5 JP 2017534056A5
Authority
JP
Japan
Prior art keywords
peptide
seq
hcv
ns3h capture
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017523343A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017534056A (ja
JP6821562B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/057845 external-priority patent/WO2016069762A2/en
Publication of JP2017534056A publication Critical patent/JP2017534056A/ja
Publication of JP2017534056A5 publication Critical patent/JP2017534056A5/ja
Application granted granted Critical
Publication of JP6821562B2 publication Critical patent/JP6821562B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017523343A 2014-10-29 2015-10-28 Ｎｓ３捕捉ペプチドを使用して対象の抗ｈｃｖ抗体を検出するアッセイ Active JP6821562B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462072266P 2014-10-29 2014-10-29
US62/072,266 2014-10-29
PCT/US2015/057845 WO2016069762A2 (en) 2014-10-29 2015-10-28 Subject anti-hcv antibody detection assays employing ns3 capture peptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021000346A Division JP2021063827A (ja) 2014-10-29 2021-01-05 Ｎｓ３捕捉ペプチドを使用して対象の抗ｈｃｖ抗体を検出するアッセイ

Publications (3)

Publication Number Publication Date
JP2017534056A JP2017534056A (ja) 2017-11-16
JP2017534056A5 true JP2017534056A5 (cg-RX-API-DMAC7.html) 2018-11-22
JP6821562B2 JP6821562B2 (ja) 2021-01-27

Family

ID=54479000

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017523343A Active JP6821562B2 (ja) 2014-10-29 2015-10-28 Ｎｓ３捕捉ペプチドを使用して対象の抗ｈｃｖ抗体を検出するアッセイ
JP2021000346A Pending JP2021063827A (ja) 2014-10-29 2021-01-05 Ｎｓ３捕捉ペプチドを使用して対象の抗ｈｃｖ抗体を検出するアッセイ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021000346A Pending JP2021063827A (ja) 2014-10-29 2021-01-05 Ｎｓ３捕捉ペプチドを使用して対象の抗ｈｃｖ抗体を検出するアッセイ

Country Status (7)

Country Link
US (3) US10088483B2 (cg-RX-API-DMAC7.html)
EP (1) EP3213083B1 (cg-RX-API-DMAC7.html)
JP (2) JP6821562B2 (cg-RX-API-DMAC7.html)
KR (1) KR102441636B1 (cg-RX-API-DMAC7.html)
CN (1) CN107110868B (cg-RX-API-DMAC7.html)
ES (1) ES2828713T3 (cg-RX-API-DMAC7.html)
WO (1) WO2016069762A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2828713T3 (es) 2014-10-29 2021-05-27 Abbott Lab Ensayos de detección de anticuerpos anti-VHC objeto usando péptidos de captura NS3
CN110996986B (zh) * 2017-07-27 2024-07-19 豪夫迈·罗氏有限公司 Hcv抗原的多表位融合蛋白及其用途
CN112341527B (zh) * 2020-09-16 2021-08-31 菲鹏生物股份有限公司 Hcv重组抗原及应用

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3750503T2 (de) 1986-10-22 1995-02-09 Abbott Lab Chemilumineszierende Acridinium- und Phenantridiniumsalze.
US5006309A (en) 1988-04-22 1991-04-09 Abbott Laboratories Immunoassay device with liquid transfer between wells by washing
US5089424A (en) 1988-06-14 1992-02-18 Abbott Laboratories Method and apparatus for heterogeneous chemiluminescence assay
US5241070A (en) 1988-09-26 1993-08-31 Ciba Corning Diagnostics Corp. Nucleophilic polysubstituted aryl acridinium esters and uses thereof
SE462454B (sv) 1988-11-10 1990-06-25 Pharmacia Ab Maetyta foer anvaendning i biosensorer
US5063081A (en) 1988-11-14 1991-11-05 I-Stat Corporation Method of manufacturing a plurality of uniform microfabricated sensing devices having an immobilized ligand receptor
HU217025B (hu) * 1990-04-04 1999-11-29 Chiron Corp. Hepatitis C vírus-(HCV) antigénkészítmények az anti-HCV-antitestek kimutatására immunoassay-kben
US6194140B1 (en) * 1990-04-04 2001-02-27 Chiron Corporation HCV NS3 protein fragments having helicase activity and improved solubility
US5135785A (en) 1990-08-13 1992-08-04 Colgate-Palmolive Company Pouch containers and films therefor
CA2048302A1 (en) 1990-08-15 1992-02-16 Victoria P. Meucci Solubilization reagent for biological test samples
US5135875A (en) 1990-08-15 1992-08-04 Abbott Laboratories Protein precipitation reagent
CA2069530A1 (en) 1991-06-03 1992-12-04 Cass J. Grandone Reagent pack for immunoassays
JP3327551B2 (ja) 1992-03-30 2002-09-24 アボツト・ラボラトリーズ 流体試料中のチロキシンを検出・定量するための試薬および方法
US5352803A (en) 1992-03-30 1994-10-04 Abbott Laboratories 5(6)-methyl substituted fluorescein derivatives
DE4428705A1 (de) * 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
NZ516848A (en) 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
CA2323638A1 (en) 1998-04-03 1999-10-14 Phylos, Inc. Addressable protein arrays
DK1071955T4 (da) * 1998-04-17 2009-06-15 Innogenetics Nv Forbedrede immundiagnostiske assays, som anvender reduktionsmidler
US6406921B1 (en) 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
WO2000056934A1 (en) 1999-03-24 2000-09-28 Packard Bioscience Company Continuous porous matrix arrays
FR2825093B1 (fr) * 2001-05-28 2003-07-18 Bio Merieux Polypeptide reagissant avecles anticorps de patients infectes par vhc et utilisations
US7101683B2 (en) * 2001-06-26 2006-09-05 Abbott Laboratories Methods for the simultaneous detection of HCV antigens and HCV antibodies
US7419821B2 (en) 2002-03-05 2008-09-02 I-Stat Corporation Apparatus and methods for analyte measurement and immunoassay
US20040018577A1 (en) 2002-07-29 2004-01-29 Emerson Campbell John Lewis Multiple hybrid immunoassay
US20040152070A1 (en) * 2003-02-04 2004-08-05 Shah Dinesh O. Method of detection of HCV antibodies in combination assay or sole antibody assay
US20050014136A1 (en) * 2003-05-28 2005-01-20 Innogenetics N.V. Modified HCV NS5
US7682833B2 (en) 2003-09-10 2010-03-23 Abbott Point Of Care Inc. Immunoassay device with improved sample closure
US7723099B2 (en) 2003-09-10 2010-05-25 Abbott Point Of Care Inc. Immunoassay device with immuno-reference electrode
US7883855B2 (en) 2006-07-21 2011-02-08 Abbott Laboratories Immunosuppressant drug extraction reagent for immunoassays
US8865398B2 (en) * 2006-09-01 2014-10-21 Abbott Laboratories Combination hepatitis C virus antigen and antibody detection method
US7858752B2 (en) 2006-12-05 2010-12-28 Abbott Laboratories Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
US7906293B2 (en) 2007-04-09 2011-03-15 Abbott Laboratories Acridinium phenyl esters useful in the analysis of biological
CN101477126A (zh) * 2008-09-24 2009-07-08 湖南景达生物工程有限公司 一种丙型肝炎病毒抗原抗体联合检测的方法
WO2012006500A2 (en) 2010-07-08 2012-01-12 Abbott Laboratories Monoclonal antibodies against hepatitis c virus core protein
JP5828728B2 (ja) * 2011-09-28 2015-12-09 株式会社日立ハイテクノロジーズ 自動分析装置
JP2016512241A (ja) * 2013-03-14 2016-04-25 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ 改良された抗体検出のためのｈｃｖｎｓ３組換え抗原およびこの突然変異体
MX362075B (es) 2013-03-14 2019-01-07 Abbott Lab Ensayo de combinación de antígeno-anticuerpo del virus de la hepatitis c (vhc) y métodos y composiciones para usarlo.
WO2014143343A1 (en) 2013-03-14 2014-09-18 Abbott Laboratories Hcv core lipid binding domain monoclonal antibodies
CN103792354B (zh) * 2014-01-28 2015-11-25 中国医学科学院基础医学研究所 一种检测丙型肝炎病毒抗体的微流控纸基芯片及其制备方法
ES2828713T3 (es) 2014-10-29 2021-05-27 Abbott Lab Ensayos de detección de anticuerpos anti-VHC objeto usando péptidos de captura NS3

Similar Documents

Publication Publication Date Title
JP5836569B2 (ja) Ｈｃｖ抗原抗体組み合わせアッセイ用の試薬
JP2011523550A5 (cg-RX-API-DMAC7.html)
JP2020501532A5 (cg-RX-API-DMAC7.html)
JP2010521147A5 (cg-RX-API-DMAC7.html)
CN104031144B (zh) 特异结合戊型肝炎病毒3、4型的抗体及其用途
JP2006502416A5 (cg-RX-API-DMAC7.html)
WO2014143343A8 (en) Hcv core lipid binding domain monoclonal antibodies
JP2012509295A5 (cg-RX-API-DMAC7.html)
JP2010501594A5 (cg-RX-API-DMAC7.html)
JP2005531286A (ja) ＨＣＶＥ２グリコプロテインに対して向けられ、ｉｎｖｉｔｒｏ中和活性を有するヒトモノクローナル抗体Ｆａｂ断片
CN108486069A (zh) 一种猪流行性腹泻病毒低含量样品的病毒分离方法
JP2017534056A5 (cg-RX-API-DMAC7.html)
JP2010523994A5 (cg-RX-API-DMAC7.html)
RU2016133598A (ru) Композиция микобактериального антигена
JP2018515071A5 (cg-RX-API-DMAC7.html)
JP2014518624A5 (cg-RX-API-DMAC7.html)
JP2011522561A5 (cg-RX-API-DMAC7.html)
CN104597256A (zh) 一条与牛病毒性腹泻病毒e2蛋白相结合的多肽序列及其应用
CN102584952B (zh) 一种丙型肝炎病毒f蛋白的抗原构象表位模拟肽及其应用
Chi et al. An engineered IgG–VHH bispecific antibody against SARS‐CoV‐2 and its variants
JP2018520127A5 (cg-RX-API-DMAC7.html)
CN104744572A (zh) 禽和猪戊型肝炎病毒共有抗原、单克隆抗体和制备方法及应用
JP2011509935A5 (cg-RX-API-DMAC7.html)
RU2014102721A (ru) Способ получения агента, связывающегося с препро-вазопрессином или с его фрагментами
CN119462863A (zh) 抗hcv核心抗原单克隆抗体、杂交瘤细胞株及应用